Peripheral blood natural killer cell counts/percentage (all treated patients). Baseline natural killer cell values are reported on cycle 1 day 1 (C1D1). C2D1, cycle 2 day 1; EOT, end of treatment (discontinuation of elotuzumab). Whiskers, confidence intervals; middle line in box, median; upper and lower limit of box, range; circles, outliers.